Bausch Health Companies (BHC) Gross Profit (2009 - 2026)

Bausch Health Companies has disclosed Gross Profit across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Gross Profit for Q1 2026 came in at $2.5 billion, up 14.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 billion (up 6.08% YoY), and the FY2025 annual result was $10.3 billion, up 11.88% from the prior year.
• Gross Profit came in at $2.5 billion for Q1 2026 at Bausch Health Companies, down from $2.8 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $3.9 billion in Q4 2022 to a low of $1.4 billion in Q1 2023.
• The 5-year median for Gross Profit is $2.2 billion (2025), against an average of $2.2 billion.
• Across the five-year window, Gross Profit sank 46.52% in 2022 and soared 56.92% in 2024, its largest moves.
• Bausch Health Companies' Gross Profit stood at $3.9 billion in 2022, then plunged by 38.89% to $2.4 billion in 2023, then rose by 3.73% to $2.4 billion in 2024, then advanced by 14.38% to $2.8 billion in 2025, then fell by 11.54% to $2.5 billion in 2026.
• The last three Gross Profit figures came in at $2.5 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.